INVO Bioscience, Inc. (INVO)

Market Cap	7.62M
Revenue (ttm)	3.59M
Net Income (ttm)	-8.27M
Shares Out	12.59M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,424
Open	0.605
Previous Close	0.605
Day's Range	0.605 - 0.640
52-Week Range	0.329 - 2.837
Beta	0.80
Analysts	Sell
Price Target	2.04 (+237.02%)
Earnings Date	May 15, 2023

About INVO

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 10
• Stock Exchange: NASDAQ
• Ticker Symbol: INVO

Financial Performance

In 2021, INVO's revenue was $4.16 million, an increase of 301.06% compared to the previous year's $1.04 million. Losses were -$6.65 million, -20.27% less than in 2020.

Analyst Forecast

According to 6 analysts, the average rating for INVO stock is "Sell." The 12-month stock price forecast is $2.04, which is an increase of 237.02% from the latest price.

Price Target

$2.04

(237.02% upside)

Analyst Consensus: Sell